Aktana equips life science companies with the decision support technology to quickly evaluate mountains of data, extracting only what’s relevant and valuable at the time of decision.
With brand strategy as a starting point, Aktana analyzes market data, channel activity and HCP preference to provide life science companies with the insights, clarity and guidance to deliver the right information at the right time to physicians and their patients.
In fact, more than half of the world's top-20 pharmaceutical companies rely on Aktana to put complex data into context, coordinate channel activity and improve sales effectiveness by up to 30 percent.
Featured
Resources
Our Customers
More than half of the top 20 global life sciences companies rely on Aktana for intelligent customer engagement, with over 250 brands around the world live today.
Latest News
View AllCOVID & Everything After, Aktana’s Jay Borowiecki speaks to MedAdNews
From remote engagement to AI-driven personalization, COVID’s impact on the pharma industry will be felt long after the pandemic subsides. Jay Borowiecki and other industry leaders predict which changes will fade and which will redefine the way we engage with HCPs for MedAdNews. Read the full article here.
Read More